Medicine
Climara Pro 0.045 mg/0.015 mg per day transdermal patch
Climara Pro 0.045 mg/0.015 mg per day transdermal patch is a prescription medicine containing Estradiol and Levonorgestrel for transdermal use, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Estradiol and Levonorgestrel
- Brand
- Climara Pro
- Strength
- 0.045 mg/0.015 mg per day
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 4 patches, 1 patch
- Marketing authorisation holder
- Bayer HealthCare Pharmaceuticals
- Manufacturer
- Bayer HealthCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Do not store unpouched.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 November 2003
- Identifiers
- RxCUI 402250, 402252DailyMed set ID 184d3092-7fc6-4375-816b-1ab06bb99cfdNDC 50419-491Application NDA021258
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 patch in 1 carton / 7 d in 1 patch | 50419-491-04 | Bayer HealthCare Pharmaceuticals | 21 November 2013 |
| 1 patch in 1 carton / 7 d in 1 patch | 50419-491-73 | Bayer HealthCare Pharmaceuticals | 12 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 November 2003 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Estradiol and Levonorgestrel 0.045 mg/0.015 mg per day transdermal patch.
Clinical summary
Estradiol and Levonorgestrel is a fixed-dose combination of an estrogen, a progestin and a progestin-containing intrauterine system indicated for climara Pro is an estrogen plus progestin indicated in a woman with a uterus for. MedsAcross supplies Estradiol and Levonorgestrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Estradiol and LevonorgestrelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Climara Pro prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Climara Pro 0.045 mg/0.015 mg per day transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.